European drug markets are transforming; cocaine access is easier, and synthetic drugs pose new risks across Europe.
[This is an automatically generated summary, for reference only]
The European Drug Report for 2026 indicates that Europe’s drug market is transforming rather than collapsing under law enforcement pressure. While cocaine seizures have decreased by weight, the number of seizures has increased due to smaller, more dispersed shipments and advanced smuggling methods. Major ports remain key entry points, but illicit networks are utilizing smaller ports, sea transfers, speedboats, underwater vessels, drones, and sophisticated hiding techniques. Spain is highlighted for its significant role in European cocaine imports and cannabis seizures. Cocaine remains a major challenge, with increased detection levels in wastewater across many cities and rising demand for related medical treatments. Cocaine-related deaths account for over a quarter of drug-related fatalities, increasingly affecting vulnerable populations like the homeless, rather than solely high-income users. Furthermore, Europe is emerging as a site for synthetic drug production, with numerous laboratories identified for substances like amphetamines and MDMA. Regarding cannabis, the report focuses on various regulatory models being tested across several countries rather than advocating for general legalization. Finally, while acknowledging room for improvement in harm reduction efforts, EUDA stated that European efforts are improving but still need to meet international standards in areas like opioid agonist treatment and needle exchange programs.
